Atlas Trials

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Clinical trial NCT06910306 · RECRUITING

Trial details

NCT number
NCT06910306
Sponsor
Alpha Tau Medical LTD.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent GlioblastomaRecurrent Gliomas
Start date
2025-10-01
Primary completion
2026-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.